Chongqing Lummy Pharmaceutical Co. Ltd. | |
Stock Exchange | Shenzhen Stock Exchange |
EPS |
CNY0.09 |
Market Cap |
CNY4.29 B |
Shares Outstanding |
671.35 M |
Public Float |
397.88 M |
Address |
15th Floor, Tower B Chongqing Chongqing 401123 China |
Employees | - |
Website | http://www.cqlummy.com |
Updated | 07/08/2019 |
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agent, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China. |